APA (7th ed.) Citation

Oh, Y., Jung, H. R., Min, S., Kang, J., Jang, D., Shin, S., . . . Cho, S. (2021). Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers. Cancer Letters, 497, 123. https://doi.org/10.1016/j.canlet.2020.10.018

Chicago Style (17th ed.) Citation

Oh, Yumi, et al. "Targeting Antioxidant Enzymes Enhances the Therapeutic Efficacy of the BCL-XL Inhibitor ABT-263 in KRAS-mutant Colorectal Cancers." Cancer Letters 497 (2021): 123. https://doi.org/10.1016/j.canlet.2020.10.018.

MLA (9th ed.) Citation

Oh, Yumi, et al. "Targeting Antioxidant Enzymes Enhances the Therapeutic Efficacy of the BCL-XL Inhibitor ABT-263 in KRAS-mutant Colorectal Cancers." Cancer Letters, vol. 497, 2021, p. 123, https://doi.org/10.1016/j.canlet.2020.10.018.